Memorial Sloan-Kettering Cancer Center maintains one of the world's most dynamic programs of cancer research. The extraordinary patient care we provide benefits from our innovative programs in basic, translational, and clinical research. Research at Sloan-Kettering Institute is dedicated to understanding the biology of cancer through programs in cell biology, genetics, biochemistry, molecular biology, structural biology, computational biology, immunology, and therapeutics.
Investigators at Sloan-Kettering Institute collaborate with Memorial Hospital physician-scientists, a partnership that helps speed important research findings from the laboratory to the bedside, in a process known as translational research. Memorial Sloan-Kettering also actively initiates and participates in clinical trials to identify more effective cancer therapies, and our physicians are currently leading more than 400 clinical trials for pediatric and adult cancers.
Established in 2005, the Human Oncology and Pathogenesis Program (HOPP) is a further effort to increase institutional research strength in areas important in contemporary translational research. HOPP is designed to meld even more thoroughly the cultures of basic biologic science and clinical oncology, augmenting the work conducted in the laboratories of Memorial Sloan-Kettering Cancer Center's physician-scientists.
|Name:Zelefsky J Michael|
|Organization:||Memorial Sloan-Kettering Cancer Center|